Brief report Quality of Life for Persons Living with Schizophrenia: More Than Just Symptoms ▼
Shaun M. Eack, Christina E. Newhill, Carol M. Anderson and Armando J. Rotondi University of Pittsburgh
Quality of life is an important outcome for persons living with schizophrenia and for the treatment of schizophrenia. However, studies of quality of life among persons living with schizophrenia have focused primarily on the symptoms experienced by the individual. This study sought to determine the influence of unmet need and social support on the quality of life of individuals with schizophrenia. Thirty-two persons living in the community with schizophrenia or schizoaffective disorder were assessed on quality of life, psychopathology, unmet need and social support. Hierarchical regression analyses indicated that unmet need and social support are important contributors to the quality of life of a person with schizophrenia, even after controlling for symptoms. Implications for schizophrenia treatment are discussed.
Keywords: schizophrenia, quality of life, recovery, functional outcome
Schizophrenia is a psychiatric disability that presents a range of challenges for those with the illness and their families. With advances in neuroleptic and psychosocial interventions, treatments have expanded beyond simply reducing the symptoms associated with schizophrenia. Treatments today increasingly focus on improving quality of life, which can be broadly conceptualized as 1) objective quality of life, or a person’s health status and access to resources and opportunities, and 2) subjective quality of life, or a person’s sense of wellbeing and satisfaction with life (Lehman, 1988). This emphasis has necessitated the elucidation of factors that affect quality of life for persons with schizophrenia. To date, most research on the determinants of quality of life in schizophrenia has focused on the impact of psychiatric symptoms, and indicated that anxiety and depressive symptoms, in particular, have an important negative impact on quality of life (see Lambert & Naber, 2004 for review). Unfortunately, investigations into the psychosocial influences of quality of life have been sparse, which has narrowed treatment development efforts and provided a limited picture with regard to the quality of life individuals with schizophrenia can attain, as if control of symptoms is the most that can be expected.
The studies that have investigated the role of factors other than psychiatric symptoms in the quality of life of individuals with schizophrenia have suggested that both social support and the meeting of basic needs (e.g., housing) have an important positive impact on quality of life (e.g., Becker, Leese, Krumm, Ruggeri, & Vazquez-Barquero, 2005; Ritsner, 2003). For example, a recent study found that improvement in social support was a significant predictor of improved quality of life among individuals with schizophrenia living on inpatient units (Ritsner, 2003). While compelling, these studies have primarily relied on subjective measurement strategies and focused largely on persons residing on inpatient units. This is limiting because different factors may influence the quality of life of individuals living in community settings, and individuals with schizophrenia may throttle their expectations for quality of life, such that subjective evaluations are inflated compared to objective life circumstances (Katschnig, 1997). As such, it is necessary to examine the influence of social support and unmet need on subjective and objective quality of life among individuals living in the community. To date, the importance of these factors, above and beyond symptoms, to individuals residing in community settings is largely unknown. Such information is vital to guiding the development of community-based interventions for enhancing quality of life among individuals with schizophrenia.
Table 1—Sample Demographic and Clinical Characteristics
This research was conducted as part of a clinical trial of a novel online psychoeducation program for individuals with schizophrenia and their families. Participants included 32 individuals with schizophrenia/schizoaffective disorder, confirmed by the Structured Clinical Interview for DSM-IV. As can be seen in Table 1, participants were all adults, predominantly female, racially diverse, and most were not employed. Quality of life was assessed using the brief version of the Lehman Quality of Life Interview (Lehman, 1988; QOLI), a reliable and valid measure of quality of life for persons with psychiatric disability. Because of the comprehensiveness of the QOLI and its large number of subscales, we computed composite indexes of both objective and subjective quality of life, by averaging across the various objective and subjective subscales.1 The objective quality of life composite included participation in leisure and daily living activities, adequacy of financial resources, and frequency of different social and familial contacts. The subjective composite included general well-being, and satisfaction with one’s familial and non-familial relations, health and safety, finances and employment, living situation, and leisure and daily living activities. The reliability of these composites were within acceptable ranges
(range of a = .70 to .87). Perceived social support was assessed with the self-report emotional/informational support subscale of Medical Outcomes Study Social Support Survey (Sherbourne & Stewart, 1991). Psychiatric symptoms experienced by individuals with schizophrenia were assessed using the expanded version of the Brief Psychiatric Rating Scale (BPRS; Lukoff, Liberman, & Nuechterlein, 1986). Both of these instruments have well-documented reliability and validity. Unmet need was assessed using a 36-item self-report scale asking participants to rate between 1 (“not at all”) and 5 (“extremely well”), how well various basic and illness-related needs were being met (Rotondi, Eack, Newhill, & Anderson, 2006). Needs ranged from basic needs related to finances and transportation, to needs surrounding information about schizophrenia and its treatment, to needs related to building friendships and community integration. We found the reliability of this instrument to be good (a = .83). Participants were recruited by staff referral from community clinics (n = 27) and acute inpatient units (n = 5) in a large urban area in an eastern state, and interviewed using the aforementioned instruments. Participants were recruited if they had a diagnosis of schizophrenia/schizoaffective disorder, were 14 years or older, and had at least one psychiatric hospitalization within the past 2 years. This study was approved by the University of Pittsburgh Institutional Review Board, and all participants gave written informed consent prior to participation.
A series of hierarchical regression analyses, controlling for age, race, and gender effects, were conducted to examine the influence, above and beyond symptoms, of unmet need and social support on quality of life, by removing shared variance between the BPRS and QOLI prior to examining the influence of these factors. Results indicated that neither demographic characteristics nor psychiatric symptoms were significantly related to objective quality of life, R2 = .04, F (1, 27) = .48, ns. Further, unmet need and perceived social support also did not explain a significant amount of variance in objective quality of life, beyond symptoms (DR2 = .16, F (2, 25) = 2.48, p = .10), with social support (b = .36, sr2 = .10, p = .09) having a marginal, non-significant contribution, and unmet need making no significant contribution (b = .16, ns). When examining the influences of subjective quality of life, psychiatric symptoms did have a substantial negative influence on quality of life, R2 = .17, F (1, 27) = 6.28, p < .05. However, both fewer unmet needs (b = .34, sr2 = .09, p < .05) and greater perceived social support (b = .37, sr2 = .11, p < .05) were also significantly related to better quality of life, and continued to explain over 25% of the variance in subjective quality of life above and beyond symptoms, DR2 = .27, F (2, 25) = 7.50, p < .01. Such findings highlight the importance not only of symptoms, but also unmet need and social support to the quality of life of persons with schizophrenia.
As newer medications are developed and control of the most troublesome symptoms of schizophrenia becomes a reality for most individuals, quality of life is emerging as an important treatment outcome. Most quality of life research has focused on the influence of symptoms, and research investigating other factors has been limited to subjective evaluations by persons residing on inpatient units. The findings from this study make an important contribution to the existing literature by demonstrating the importance of unmet need and perceived social support to the subjective quality of life of individuals living in the community with this disability. Although this study is limited by its cross-sectional design and small sample size, which may restrict the representativeness of our sample and generalizability of these results, these findings do provide further evidence that community-based interventions designed to improve quality of life should encompass both treatment to reduce the symptoms experienced by individuals with schizophrenia, along with interventions designed to enhance social support and address unmet needs, such as basic financial needs and the need for information about the illness. For psychosocial rehabilitation researchers, these findings are not surprising. In fact, an understanding of the importance of unmet need and social support has been the impetus for the development of many of the psychosocial rehabilitation services that exist today, yet research on quality of life seems to have neglected these factors. Furthermore, community treatment continues to consist primarily of prophylactic antipsychotic medication and little, if any evidence-based psychosocial interventions. This research suggests that if we want to help individuals with schizophrenia lead full and satisfying lives, treatment developers need to attend to the psychosocial influences of quality of life, and substantial work needs to be done to ensure these interventions reach persons in the community, as these interventions are the most likely to satisfy unmet needs and enhance social support, and therefore improve the quality of life of the many individuals living in the community who experience this disability
Becker, T., Leese, M., Krumm, S., Ruggeri, M., & Vazquez-Barquero, J. L. (2005). Needs and quality of life among patients with schizophrenia in five European centres: What is the impact of global functioning scores. Social Psychiatry and Psychiatric Epidemiology, 40(8), 628–634.
Katschnig, H. (1997). How useful is the concept of quality of life in psychiatry. Current Opinion in Psychiatry, 10(5), 337–345.
Lambert, M., & Naber, D. (2004). Current issues in schizophrenia: Overview of patient acceptability, functioning capacity and quality of life. CNS Drugs, 18(Suppl2), 5–17.
Lehman, A. F. (1988). A Quality of Life Interview for the chronically mentally ill. Evaluation & Program Planning, 11(1), 51–62.
Lukoff, D., Liberman, R. P., & Nuechterlein, K. H. (1986). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin, 12(4), 578–593.
Ritsner, M. (2003). Predicting changes in domain-specific quality of life of schizophrenia patients. Journal of Nervous & Mental Disease, 191(5), 287–294.
Rotondi, A. J., Eack, S. M., Newhill, C. E., & Anderson, C. M. (2006). Assessing need in schizophrenia. Manuscript in preparation.
Sherbourne, C. D., & Stewart, A. L. (1991). The MOS social support survey. Social Science & Medicine, 32(6), 705–714.
Shaun M. Eack, MSW, is a doctoral student at the School of Social Work, University of Pittsburgh.
Christina E. Newhill, PhD, is Associate Professor of Social Work at the School of Social Work, University of Pittsburgh.
Carol M. Anderson, PhD, is Professor of Psychiatry at the Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine.
Armando J. Rotondi, PhD, is Associate Professor at the Department of Critical Care Medicine, Department of Health Policy and Management, University of Pittsburgh.
Correspondence concerning this article should be addressed to Armando J. Rotondi, University of Pittsburgh, Department of Critical Care Medicine, 612B Scaife Hall, Pittsburgh, PA 15213. Phone: 412/648-9939. E-mail: firstname.lastname@example.org
This research was supported by an NIMH grant to Dr. Rotondi (MH-63484).